Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice

Grishchenko, M; Grieve, RD; Sweeting, MJ; de Angelis, D; Thomson, BJ; Ryder, SD; Irving, WL; Trent, HCVSG; (2009) Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice. International journal of technology assessment in health care, 25 (2). pp. 171-180. ISSN 0266-4623 DOI: https://doi.org/10.1017/S0266462309090229

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1017/S0266462309090229

Abstract

Share

Download

Filename: IL2.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar